Gastro Education 2018
Journal of Clinical Gastroenterology and Hepatology
ISSN: 2575-7733
Page 19
September 06-07, 2018
London, UK
14
th
International Conference on
Gastro Education
Background:
Egypt has the highest prevalence of hepatitis
C virus in the world with infection rate up to 60%, for which
liver fibrosis or hepatic carcinoma is the final outcome.
Stem cell therapy provides a new hope for hepatic repair
instead of traditional treatment, liver transplantation, as it
is safer, gives long term engraftment and avoid expensive
immunosuppressive drugs and unexpected hazardous effects.
Aim:
This work aimed at determining the therapeutic potential
of mesenchymal stem cells (MSC) in hepatic repair as a new
line of therapy for liver fibrosis.
Methods:
Thirty three female albino rats were divided into three
groups: Group I: 10 rats injected subcutaneously with olive oil,
Group II: 13 rats injected with carbon tetrachloride (CCl4) and
Group III: 10 rats injected with CCl4 then bone marrow derived
MSC frommale rats. Blood and liver tissue samples were taken
from all rats for biochemical and histological study.
Results:
Liver functions for group II rats showed significant
deterioration in response to CCl4 in addition to significant
histological changes in liver lobules and portal areas. Those
parameters tend to be normal in MSC-treated group. Group III
rats revealed normalized liver function and histological picture.
Meanwhile, most of the pathological lesions were still detected
in rats of second group.
Conclusions:
Undifferentiated MSCs have the ability to
ameliorate CCl4 induced liver injury in albino rats in terms of
liver functions and histological features. So, stem cell therapy
can be considered clinically to offer a hope for patients
suffering from liver fibrosis.
Biography
Nermin Raafat pursued her MD-PhD from University of Basel, Switzerland.
She is currently an Assistant Professor of Medical Biochemistry and Mo-
lecular Biology at Zagazig University School of Medicine, Egypt. She is the
Director of Molecular Biology and Cell Culture Lab in the Department; Head
of Cell Culture Unit of Scientific and Medical Research Centre; Director of
Project Management Unit; Admin of Institutional Review Board and a Mem-
ber of Scientific Research Council at the same university. She has published
more than 30 papers in reputed journals and has participated in more than
30 international conferences.
nerminraafat@gmail.comMesenchymal stem cells:
in vivo
therapeutic application
ameliorates carbon tetrachloride induced liver fibrosis in rats
Nermin Raafat, Sara M Abdel Aal, Fadia K Abdo
and
Nabila M El Ghonaimy
Zagazig University, Egypt
Nermin Raafat et al., J Clin Gastroenterol Hepatol 2018, Volume 2
DOI: 10.21767/2575-7733-C2-005




